<DOC>
	<DOC>NCT00645203</DOC>
	<brief_summary>To evaluate the safety and efficacy of cefdinir oral suspension in children between 6 months and 4 years of age, with acute otitis media, who are at risk of persistent or recurrent otitis media.</brief_summary>
	<brief_title>Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Cefdinir</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Male and female children between 6 months and 4 years of age Weight does not exceed 40 kg Clinical diagnosis is acute otitis media Have evidence of middle ear fluid At risk for persistent or recurrent otitis media Generally in good health Sensitivity or allergy to penicillins or cephalosporins or inability to take oral medications Presence of tympanostomy tubes, ventilation tube or perforated tympanic membrane, in either ear Treatment with any antiinfective agent within 3 days prior to the study or treatment with a longacting injectable antimicrobial agent (e.g. , penicillin G benzathine) within 4 weeks prior to the study Concomitant infection, that requires additional antimicrobial therapy Presence of a disease, complicating factor (e.g., mastoiditis), or structural abnormality that would preclude evaluation of the patient's therapeutic response</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>